Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 3:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3217–3240 of 3,420 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Routine Clear all

Conditions: Hypercholesterolemia
Interventions: ALIROCUMAB SAR236553 (REGN727); Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: Female only
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: Breast Cancer
Interventions: Dual Energy Contrast Enhanced Digital Mammography (DE CEDM); Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypoxia, Apnea, Hypotension, Hypopnea
Interventions: Capnographic Monitoring; Diagnostic Test
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Independence, Ohio

Conditions: Hearing Loss
Interventions: Hearing Aid; Device
Lead sponsor: University of Nebraska Lincoln; Other
Eligibility: 40 Years to 75 Years
Enrollment: 209 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Diabetic Macular Edema (DME), Age-Related Macular Degeneration (AMD), Retinal Vein Occlusion, Diabetic Retinopathy (DR)
Interventions: Chloroprocaine Ophthalmic Gel 3% (IHEEZO), Sham Subconjunctival Injection, Proparacaine Hydrochloride Ophthalmic Solution 0.5%, Lidocaine Hydrochloride Injection 2%; Drug · Procedure
Lead sponsor: Harrow Inc; Industry
Eligibility: 18 Years and older
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Tyler, Texas

Conditions: Cochlear Implant, Cochlear Implant Users, Cochlear Implant Recipients, Cochlear Implant Listeners
Interventions: AC Group, CA group; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 95 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Infertility, Obesity, Diminished Ovarian Reserve (DOR), Diminished Ovarian Reserve
Interventions: Follicle Stimulating Hormone; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 19 Years to 37 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2032
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Femoral Shaft Fracture
Interventions: Conservative (non-surgical) treatment, Surgical treatment; Procedure
Lead sponsor: AO Innovation Translation Center; Other
Eligibility: Up to 16 Years
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Health Care Disparities
Interventions: Shared decision making tip sheet; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pain, Postoperative
Interventions: Cold therapy via reusable cold gel pack; Device
Lead sponsor: Cleveland Clinic Florida; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Osteonecrosis
Interventions: Ferumoxytol-enhanced magnetic resonance imaging, Magentic Resonance Imaging; Drug · Device
Lead sponsor: Stanford University; Other
Eligibility: 8 Years to 40 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Thyroid Eye Disease (TED), Graves Ophthalmopathy, Thyroid Associated Ophthalmopathies
Interventions: Smartphone-based AI self-monitoring application (Glandy CAS/EXO/LID); Device
Lead sponsor: THYROSCOPE INC.; Industry
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Jose, California

Conditions: Acute Kidney Injury
Interventions: Study Physician/Advance Practice Provider, Nurse Navigator, Pharmacist, Patient Education; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 2,145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 9
States / cities: Birmingham, Alabama • New Haven, Connecticut • Weston, Florida + 3 more

Conditions: Cosmetic Procedures
Interventions: VeinViewer; Device
Lead sponsor: Christie Medical Holdings, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: La Jolla, California • Hunt Valley, Maryland

Conditions: Hearing Loss, Speech and Language Development Delay Due to Hearing Loss
Interventions: Speech-Language Teletherapy; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 0 Months to 27 Months
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 5
States / cities: Oakland, California • Palo Alto, California • San Diego, California + 2 more

Conditions: Parkinson Disease
Interventions: Intraoperative Behavioral Testing, Behavioral Testing; Diagnostic Test
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 89 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Leukemia, Chronic Myeloid, Cancer
Interventions: EMPATHY Pilot; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Augusta, Georgia • Chicago, Illinois

Conditions: Physical Therapy
Interventions: Verbal Advice, Bathroom Scale, Loadsol Biofeedback; Other · Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Body Image
Interventions: Body confidence podcast episode and supplementary exercises in a journal, Body confidence podcast episode, Non-body image-related podcast episode; Behavioral
Lead sponsor: University of the West of England; Other
Eligibility: 29 Years to 44 Years · Female only
Enrollment: 1,351 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypoglycemia Hyperglycemia
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 1 Day to 21 Years
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Atlanta, Georgia • Macon, Georgia

Conditions: Iron Deficiency Anemia
Interventions: Iron Supplement, multivitamin; Dietary Supplement
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 24 Weeks to 32 Weeks
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Nonmalignant Neoplasm
Interventions: biologic sample preservation procedure, cytology specimen collection procedure; Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 120 Years
Enrollment: 15,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2040
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Down Syndrome, Adaptive Behavior, Quality of Life
Interventions: The MapHabit System; Device
Lead sponsor: MapHabit, Inc.; Industry
Eligibility: 7 Years to 17 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Autism Spectrum Disorder
Interventions: Surviving and Thriving in the Real World, Program for the Education and Enrichment of Relational Skills; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 15 Years to 22 Years
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Cincinnati, Ohio

Search by objective public record fields.

Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study

Digital Mammography for the Detection and Preoperative Staging of Breast Cancer

Use of Capnography in EGD and Colonoscopy With Moderate Sedation.

Restoration of Spectral Resolution With Hearing-aid Amplification

Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections

Patient-Oriented Research to Optimize Cochlear Implant Outcomes

Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome

Pediatric Femur Fracture Registry

Mitigating Racial Disparities in Shared Decision Making in the Intensive Care Unit

Effect of Cold Therapy Implementation on Multi-modal Postoperative Pain Management

Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI

Prospective Observational Study of Smartphone-Based AI Self-Monitoring During Non-Surgical Treatment for Thyroid Eye Disease (THYROSCOPE)

A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial

Cosmetic Dermatology Study

Teletherapy in Children Who Are Deaf and Hard of Hearing

Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease

The EMPATHY Pilot Study

Real-Time Biofeedback on Partial Weightbearing Training

The Impact of a Podcast-based Body Image Intervention Among Millennial Women

Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry

Trial Comparing Iron Supplementation Versus Routine Iron Intake in Very Low Birth Weight Infants

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Life Skills Improved in Children With Down Syndrome After Using Assistive Technology

Daily Living Skills Intervention for Adolescents With Autism Spectrum Disorder